Smart contact lens keeps an eye on your eyes-even when they’re closed: Study

A new kind of smart contact lens is poised to revolutionize how we monitor eye health. Designed to work even when the eyes are closed, this stretchable lens combines pressure and movement sensing in one compact, wireless system. It offers a noninvasive, high-resolution way to track key ocular signals like intraocular pressure (IOP) and eye movement (EM)-factors critical for managing chronic conditions such as glaucoma. Successfully tested in both animal and human models, the lens provides accurate, real-time data to external devices without disrupting vision or comfort. This innovation could mark a turning point in how we detect and manage eye diseases.

Vision disorders impact over a billion people worldwide, with glaucoma being one of the most insidious due to its slow, symptomless progression. Key biomarkers like elevated IOP and irregular eye movement (EM) often go unnoticed, especially during sleep, when traditional open-eye instruments fall short. Nocturnal like intraocular pressure (IOP) spikes and rapid eye movement (REM)-related EM events are particularly important for diagnosing and preventing damage. Smart contact lenses have emerged as a promising solution, but most are limited to open-eye use and struggle to capture dual-modal data with precision. Because of these limitations, there’s a growing need for wearable devices that can deliver continuous, closed-eye monitoring with both accuracy and comfort.

Now, researchers from the University of Electronic Science and Technology of China have developed a next-generation smart contact lens that does exactly that. Published (DOI: 10.1038/s41378-025-00946-y) in Microsystems & Nanoengineering in May 2025, the study unveils a soft, stretchable bimodal contact lens (BCL) capable of simultaneously monitoring IOP and EM, even with the eyelids shut. By integrating capacitive and magnetic sensors into a single, wirelessly connected platform, the device enables round-the-clock tracking of eye health, offering a new pathway toward personalized, proactive care.

The BCL combines five layers of carefully engineered materials, including serpentine copper coils for pressure sensing and a neodymium-infused magnetic film for movement detection. This flexible structure allows the lens to contour naturally to the eye, avoiding discomfort and preserving vision. In rabbit models, the lens demonstrated high sensitivity to IOP fluctuations, with resolution as fine as 1 mmHg and superior signal stability even when eyes were closed. EM detection achieved over 97% accuracy in both lab models and human trials, thanks to an integrated glasses-mounted Tesla meter array. Data from the lens are wirelessly relayed to mobile devices, supporting real-time feedback. Importantly, biocompatibility testing confirmed the device is safe for extended wear, with no signs of inflammation or visual disruption. Together, these features present a rare combination of precision, comfort, and practicality for clinical and everyday use.

“This technology bridges a long-standing gap in ophthalmic care,” says Dr. Guang Yao, co-lead author of the study. “The ability to monitor both IOP and EM continuously—even when the eyes are closed-offers a more complete picture of eye health. It enables early intervention and more accurate tracking of disease progression, particularly for glaucoma patients. And because it’s wireless and wearable, it can be used comfortably at home, not just in clinics.”

Beyond glaucoma, this dual-sensing lens could prove useful in monitoring attention-related disorders, neurodegenerative conditions, and even sleep quality through EM patterns. Its wireless integration with mobile devices means patients can share data with physicians remotely, supporting telemedicine and reducing clinical visits. Future versions may incorporate drug delivery features, turning the lens into a closed-loop diagnostic and therapeutic system. With its customizable design and proven safety, the BCL platform opens up new possibilities for smart medical wearables in personalized healthcare.

Reference:

Gan, X., Yao, G., Li, C. et al. Closed-eye intraocular pressure and eye movement monitoring via a stretchable bimodal contact lens. Microsyst Nanoeng 11, 83 (2025). https://doi.org/10.1038/s41378-025-00946-y

Powered by WPeMatico

NMC Allows 30 percent faculty posts in 5 depts to be filled by Medical MSc, PhD degree holders

NMC Allows Appointing Medical MSc, PhD degree holders as 30 percent faculty in 5 depts

The National Medical Commission (NMC) Medical Institutions (Qualifications of Faculty) Regulations have allowed medical MSc, PhD degree holders to be appointed as faculty in Anatomy, Biochemistry, Physiology, Pharmacology, and Microbiology departments.

This follows a 2020 change that reduced non-medical faculty appointments in these departments to 15%, with some departments like Microbiology and Pharmacology restricted to 0%. The 2025 regulations restore non-medical faculty appointments to 30% in these subjects.

The Apex Medical Commission recently released the final Medical Institutions (Qualifications of Faculty) Regulations, 2025, in the official Gazette on June 30, 2025, and laid down the eligibility qualifications of medical teachers at medical institutes.

Relaxing the existing norms for appointing non-medical faculty in medical colleges, NMC has specified in these new regulations that non-MBBS holders can teach in Anatomy, Biochemistry, Physiology, Pharmacology, and Microbiology Departments in medical colleges if they possess a Master of Science or Doctor of Philosophy Degree in the respective fields of Medical Anatomy, Medical Biochemistry, Medical Physiology, Medical Pharmacology, and Medical Microbiology.

For more information, click on the link below:

NMC Allows Appointing Medical MSc, PhD degree holders as 30 percent faculty in 5 depts

Powered by WPeMatico

Amidst NMC inspection bribery scandal, demand for restructuring NMC intensifies

Amidst controversy over NMC inspection bribery scandal, demand for restructuring NMC escalates

Amidst the ongoing controversy surrounding the corruption case involving inspection-related malpractice in the medical education sector in India, the institutions have urged the Prime Minister of India (PMO) to ensure the strengthening of the National Medical Commission (NMC) for autonomous, transparent, and accountable medical education reform.

The Association of National Board Accredited Institutions (ANBAI) has urged PM Modi to restructure the Apex Medical Commission, use technology-based assessment methods, and align educational priorities with public health needs.

This representation comes after the Central Bureau of Investigation (CBI) busted a systemic corruption racket in the medical education sector and booked 34 individuals, including officials from the Union Health Ministry and the National Medical Commission (NMC), for their alleged involvement in manipulating the regulatory framework for private medical colleges. Among those named in the FIR are eight officials from the Union Health Ministry, a National Health Authority officer, and five doctors from the NMC’s inspection team. Prominent private medical college figures have also been implicated.

For more information, click on the link below:

Amidst controversy over NMC inspection bribery scandal, demand for restructuring NMC escalates

Powered by WPeMatico

Data show teclistamab can benefit many multiple myeloma patients who would have been ineligible for pivotal trial

Teclistamab-cqyv is a T-cell-engaging bispecific antibody that targets multiple myeloma cells via the B-cell maturation antigen (BCMA) receptor. It received accelerated approval in 2022 for patients treated with four or more lines of prior therapy based on results from the Phase I/II MajesTEC-1 clinical trial.

Powered by WPeMatico

Can one video change a teen’s mindset? New study says yes—but there’s a catch

A mental health hack designed to promote mental well-being could shift how teenagers view themselves—according to new research from the University of East Anglia.

Powered by WPeMatico

Can psychedelic mushrooms turn back the clock? Study suggests psilocybin preserves telomere length

A compound found in psychedelic mushrooms may have antiaging properties. Researchers at Baylor College of Medicine have found that psilocybin, the active compound in psychedelic mushrooms, may extend both cellular and organismal lifespans.

Powered by WPeMatico

Health system partnership may help cut senior emergency room visits

An innovative partnership between a health system and local congregations in neighborhoods with high need that provides individual companionship to older adults has found significant reductions in loneliness and a corresponding reduction in emergency department visits.

Powered by WPeMatico

Key mechanisms of enzyme involved in rare metabolic disease identified

An international research team has published a study in the journal The FEBS Journal that significantly advances the knowledge of a rare hereditary metabolic disease: classical homocystinuria. The team was coordinated by the Liver Diseases and Computational Chemistry groups at the CIC bioGUNE research center, member of BRTA.

Powered by WPeMatico

Elevated Fibrinogen/Albumin Ratio Signals Higher Risk of Kidney Injury in CHF Patients Undergoing CAG: Study Finds

China: A recent study published in the Journal of Inflammation Research highlights the significance of the fibrinogen/albumin ratio (FAR) as an independent predictor for the development of contrast-induced acute kidney injury (CI-AKI) in patients with congestive heart failure (CHF). The findings suggest that FAR may serve as a simple yet effective biomarker for early risk stratification in this high-risk population.

Patients with congestive heart failure face a heightened risk of mortality and poor clinical outcomes, particularly when undergoing contrast-enhanced procedures. One significant complication is contrast-induced acute kidney injury, which can further impair renal function and worsen prognosis. While the fibrinogen/albumin ratio has emerged as a potential inflammatory marker, its association with the risk of CI-AKI or all-cause mortality in CHF patients has not been well established.

To address this gap, GuangHui Zhang, First Clinical Medical College, Guangdong Medical University, Zhanjiang, Guangdong, People’s Republic of China, and colleagues investigated the correlation between preoperative FAR levels and the occurrence of CI-AKI and overall mortality in individuals with CHF.

For this purpose, the researchers conducted a retrospective observational study involving CHF patients undergoing coronary angiography (CAG). The patients were categorized into groups based on their fibrinogen/albumin ratio (FAR) quartiles. To evaluate the relationship between FAR and clinical outcomes, the researchers employed multivariate logistic regression and restricted cubic spline (RCS) analyses.

The study revealed the following findings:

  • The study included 7,235 CHF patients, with a mean age of 65.8 ± 11.7 years.
  • Among the participants, 2,100 (29.0%) were female, and 1,094 (15.1%) developed CI-AKI.
  • A non-linear relationship was observed between FAR and CI-AKI, with the risk of CI-AKI increasing as FAR increased.
  • After adjusting for confounding variables, patients with FAR > 0.150 had the highest risk of CI-AKI (OR = 1.572).
  • Multivariate COX proportional risk model revealed that patients with FAR > 0.150 had the highest risk of all-cause mortality (HR = 1.20).

The authors of this study concluded that the fibrinogen/albumin ratio is an independent risk factor for the occurrence of contrast-induced acute kidney injury in patients with congestive heart failure undergoing coronary angiography. They emphasized that assessing FAR before the procedure could help clinicians identify high-risk patients and implement strategies to prevent CI-AKI.

The study has several limitations, including its retrospective design, which may introduce biases. It did not assess blood viscosity indicators or specific CI-AKI biomarkers like cystatin C, NGAL, or KIM-1. Additionally, dynamic changes in FAR were not analyzed, and further research is needed to explore their impact on long-term renal function in CHF patients.

Reference:

Zhang G, Huang D, Chen J, Yang X, Ruan H, Huang X. Fibrinogen/Albumin Ratio is Associated with the Occurrence of Contrast-Induced Acute Kidney Injury in Patients with Congestive Heart Failure. J Inflamm Res. 2025;18:5149-5159. https://doi.org/10.2147/JIR.S507160

Powered by WPeMatico

Delayed Puberty in Boys Linked to Higher Risk of Type 2 Diabetes: Study

A new study study presented at a joint meeting of the European Society of Paediatric Endocrinology and the European Society of Endocrinology, boys who experience delayed puberty are 2.5 times more likely to develop type 2 diabetes in early adulthood. This increased risk is independent of weight and socioeconomic status, highlighting pubertal timing as a key factor in long-term metabolic health.

Type 2 diabetes affects more than 90% of diabetics and is influenced by genetic, environmental, demographic, and socioeconomic variables. Previously known as adult-onset diabetes, type 2 diabetes often strikes individuals 45 years of age or older, but it is also increasingly being diagnosed in children, teenagers, and young adults, and researchers are looking at the different risk factors. Uncertainty surrounds the association between male delayed puberty and adult-onset type 2 diabetes. Therefore, Orit Pinhas-Hamiel and colleagues looked at the relationship between the chance of acquiring type 2 diabetes in early adulthood and delayed puberty throughout adolescence.

Nearly, 9,64,108 Israeli teenage boys (mean age 17.3 years) who were screened before military enlistment between 1992 and 2015 and monitored until December 31, 2019, were the subjects of this population-based study conducted nationally. Board-designated specialists used laboratory testing and physical examination to diagnose delayed puberty. The Israeli National Diabetes Registry was connected to the data. We used Cox proportional hazard models.

Almost, 0.45% of teenage boys were diagnosed with delayed puberty. Over a total follow-up of 15,242,068 years, T2D was identified in 6,259 people without delayed puberty and 111 people (2.58%) with delayed puberty. Teenagers without delayed puberty had an incidence rate of 41.3 T2D per 105 person-years, whereas those with delayed puberty had an incidence rate of 140.3.

After adjusting for birth year, socioeconomic position, cognitive function, education level, and country of birth, the hazard ratio (HR) for T2D among those with delayed puberty remained almost constant at 2.52. The HR was 1.37 with further modification to the baseline BMI. When limited to those diagnosed at or before the age of 35, the link was much stronger (1.65), and it remained after adjusting for baseline health condition.

Using adolescents without hypogonadism as the baseline group, the adjusted HR was 1.31 in a sensitivity analysis restricted to overweight and obese adolescents. Overall, independent of baseline BMI and other variables, teenage boys who have delayed puberty have a much higher risk of developing type 2 diabetes in their early adult years. These results point to delayed puberty as a possible indicator of metabolic risk that needs more research.

Source:

Pinhas-Hamiel, O., Simchoni, M., Derazne, E., Bardugo, A., Bendor, C. D., Vinograd, A., Lutski, M., Zucker, I., Afek, A., & Twig, G. (2025). Delayed puberty and early-onset type 2 diabetes: a nationwide cohort study of 1.6 million adolescents. Endocrine Abstracts. https://doi.org/10.1530/endoabs.110.oc2.6

Powered by WPeMatico